2015
DOI: 10.1016/j.jconrel.2014.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

Abstract: Targeted delivery of therapeutics is an alternative approach for the selective treatment of infectious diseases. The surface of African trypanosomes, the causative agents of African trypanosomiasis, is covered by a surface coat consisting of a single variant surface glycoprotein, termed VSG. This coat is recycled by endocytosis at a very high speed, making the trypanosome surface an excellent target for the delivery of trypanocidal drugs. Here, we report the design of a drug nanocarrier based on poly ethylen g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
51
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 73 publications
(54 citation statements)
references
References 62 publications
2
51
1
Order By: Relevance
“…Hereby, nanoparticles loaded with pentamidine [i.e., drug used for treating the early disease stage, before central nervous system involvement (87), as the second-line option to suramin] were coupled to Nb-33. This targeted drug-bullet allowed decreasing the half-inhibitory concentration (IC50) 7-fold compared to free drug in vitro and cured all mice at a 10-fold lower dose than the minimal full curative dose of free pentamidine (8890). Moreover, recently an improved version of this nanocarrier allowed reducing the curative dose 100-fold and circumvented drug resistance that is due to mutations in aquaglyceroporin 2 (i.e., the surface channel protein that mediates pentamidine uptake in T. brucei ) (29, 91, 92).…”
Section: Nbs As Versatile Tools For Atmentioning
confidence: 99%
“…Hereby, nanoparticles loaded with pentamidine [i.e., drug used for treating the early disease stage, before central nervous system involvement (87), as the second-line option to suramin] were coupled to Nb-33. This targeted drug-bullet allowed decreasing the half-inhibitory concentration (IC50) 7-fold compared to free drug in vitro and cured all mice at a 10-fold lower dose than the minimal full curative dose of free pentamidine (8890). Moreover, recently an improved version of this nanocarrier allowed reducing the curative dose 100-fold and circumvented drug resistance that is due to mutations in aquaglyceroporin 2 (i.e., the surface channel protein that mediates pentamidine uptake in T. brucei ) (29, 91, 92).…”
Section: Nbs As Versatile Tools For Atmentioning
confidence: 99%
“…These robust multifunctional PLGA NPs could have a great potential in active tumor-targeting delivery of various drugs and proteins. [41][42][43] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 15 following HA coating have an excellent stability. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 16 drug concentrations of 0.01-10 µg/mL ( Figure 3B)…”
Section: Synthesis Of Vitamin E-nhmentioning
confidence: 99%
“…Another approach is to couple pentamidine, a first-line antitrypanosomiasis, to VHH An33 to effectively target the drug to the parasite. In vivo, a ten-fold lower dose than the minimal full curative dose of free pentamidin incorporated into this conjugate cured all infected mice, wheras a 100-fold lower dose cured 60% of them [62]. Parasite development in the tsetse fly and subsequent spread of the parasite can be controlled through the expression of trypanolytic VHHs in genetically modified tsetse fly symbionts [63].…”
Section: Trypanosomiasismentioning
confidence: 99%